Get startedLog in
    Picture of Greenlight Biosciences Holdings PBC logo

    GRNA — Greenlight Biosciences Holdings PBC News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro Cap
    All News

    Brief: Greenlight Biosciences Receives Approval To Initiate Phase I/II Clinical Trial Of Covid-19 mRNA Vaccine Candidate

    Picture of Greenlight Biosciences Holdings PBC logoGreenlight Biosciences Holdings PBC
    01/02/2023 12:23
    Feb 1 (Reuters) - Greenlight Biosciences Holdings PBC
 GRNA.O :
    * GREENLIGHT BIOSCIENCES RECEIVES APPROVAL TO INITIATE PHASE
I/II
CLINICAL TRIAL OF COVID-19 MRNA VACCINE CANDIDATE
    * GREENLIGHT BIOSCIENCES HOLDINGS PBC - RWANDA FDA GIVEN
REGULATORY APPROVAL TO START PHASE I/II CLINICAL TRIAL OF
COVID-19 VACCINE CANDIDATE IN RWANDA

Source text for Eikon:  ID:nGNX1dx38y 
Further company coverage:  GRNA.O 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Greenlight Biosciences Holdings PBC

    See all news